Image designed by Cannabis Club Australia. Prescribing THC and CBD for psychiatric conditions is increasing in Australia, despite limited clinical evidence. New research by the University of Sydney reveals that healthcare practitioners are prescribing medicinal cannabis for conditions like anxiety and depression, even though evidence supporting its effectiveness is scarce.
Dr. Elizabeth Cairns from the Lambert Initiative for Cannabinoid Therapeutics explained that many patients using medicinal cannabis have unmet mental health needs and may have not responded to conventional treatments. The study highlights a significant "evidence gap" in cannabis’ effectiveness for mental health conditions, including anxiety, ADHD, and depression.
Data from the Australian Therapeutic Goods Administration shows a sharp rise in medicinal cannabis prescriptions since its legalization in 2016, with anxiety being the second most common condition treated after chronic pain. The research emphasizes the need for more studies to assess the effectiveness of THC and CBD products in improving mental health.
The Lambert Initiative aims to bridge this gap through clinical trials and calls for increased funding to better understand the impact of medicinal cannabis on mental health and quality of life. 👉 Read the full story: https://www.sydney.edu.au/news-opinion/news/2023/06/06/patients-with-unmet-mental-health-needs-turning-to-medicinal-cannabis.html
#MedicinalCannabis #MentalHealth #CannabisResearch #THC #CBD #AnxietyRelief #DepressionTreatment #ADHDTreatment #CannabisScience #CannabinoidTherapy #AustralianResearch #MentalHealthInnovation #ClinicalTrials #CannabisPrescribing #HealthResearch #EvidenceGap #PsychiatricCare #AnxietyTreatment #MedicinalCannabisAustralia #LambertInitiative #MentalHealthMatters #CannabisClubAustralia
Comments